Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

Open access
Loyer, Xavier, Paradis, Valérie, Hénique, Carole, Vion, Anne-Clémence, Colnot, Nathalie, Guerin, Coralie L, Devue, Cécile, On, Sissi, Scetbun, Jérémy, Romain, Mélissa, Paul, Jean-Louis, Rothenberg, Marc E, Marcellin, Patrick, Durand, François, Bedossa, Pierre, Prip-Buus, Carina, Baugé, Eric, Staels, Bart, Boulanger, Chantal M, Tedgui, Alain, Rautou, Pierre-Emmanuel · 2016 · Gut

Abstract

Objective: Previous studies suggested that microRNA-21 may be upregulated in the liver in non-alcoholic steatohepatitis (NASH), but its role in the development of this disease remains unknown. This study aimed to determine the role of microRNA-21 in NASH. Design: We inhibited or suppressed microRNA-21 in different mouse models of NASH: (a) low-density lipoprotein receptor-deficient ( Ldlr −/− ) mice fed a high-fat diet and treated with antagomir-21 or antagomir control; (b) microRNA-21-deficient and wild-type mice fed a methionine-choline-deficient (MCD) diet; (c) peroxisome proliferation-activator receptor α (PPARα)-deficient mice fed an MCD diet and treated with antagomir-21 or antagomir control. We assessed features of NASH and determined liver microRNA-21 levels and cell localisation. MicroRNA-21 levels were also quantified in the liver of patients with NASH, bland steatosis or normal liver and localisation was determined. Results: Inhibiting or suppressing liver microRNA-21 expression reduced liver cell injury, inflammation and fibrogenesis without affecting liver lipid accumulation in Ldlr −/− fed a high-fat diet and in wild-type mice fed an MCD diet. Liver microRNA-21 was overexpressed, primarily in biliary and inflammatory cells, in mouse models as well as in patients with NASH, but not in patients with bland steatosis. PPARα, a known microRNA-21 target, implicated in NASH, was decreased in the liver of mice with NASH and restored following microRNA-21 inhibition or suppression. The effect of antagomir-21 was lost in PPARα-deficient mice. Conclusions: MicroRNA-21 inhibition or suppression decreases liver injury, inflammation and fibrosis, by restoring PPARα expression. Antagomir-21 might be a future therapeutic strategy for NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2014-308883

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 171

Metadata

Authors
Loyer, X., Paradis, V., Hénique, C., Vion, A.-C., Colnot, N., Guerin, C. L., Devue, C., On, S., Scetbun, J., Romain, M., Paul, J.-L., Rothenberg, M. E., Marcellin, P., Durand, F., Bedossa, P., Prip-Buus, C., Baugé, E., Staels, B., Boulanger, C. M., Tedgui, A., & Rautou, P.-E.
Venue
Gut
Publisher
BMJ
Published
2015-09-03
Volume
65
Issue
11
Pages
1882-1894
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2158868597
Cited by
171
References
12
FWCI
8.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. https://app.cochat.ai/papers/10.1136/gutjnl-2014-308883
The paper
Loyer, X., Paradis, V., Hénique, C., Vion, A.-C., Colnot, N., Guerin, C. L., Devue, C., On, S., Scetbun, J., Romain, M., Paul, J.-L., Rothenberg, M. E., Marcellin, P., Durand, F., Bedossa, P., Prip-Buus, C., Baugé, E., Staels, B., Boulanger, C. M., . . . Rautou, P.-E. (2016). Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut. https://doi.org/10.1136/gutjnl-2014-308883

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.